ASCO News: Bristol and Pfizer report favorable results

Chicago, where thousands in the cancer world gather each year.Adam Feuerstein/STAT

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54.

Matthew Herper covers medical innovation — both its promise and its perils.

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You can reach Angus on Signal at angus.08.

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.

We’re ASCOmaxxing.

Adam Feuerstein, Matthew Herper, and Angus Chen are all set to delve into the ASCO annual meeting to deliver the latest cancer news, analysis, and event coverage, without needing to enhance their jawlines.

STAT+ Exclusive Story

STAT+